Samalin Investment Counsel’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Samalin Investment Counsel’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,050	Closed	-$237K	–	247
2020 Q4	$237K	Hold	2,050	–	–	0.18%	187
2020 Q3	$200K	Buy	2,050 +393	+24%	+$45.2K	0.18%	173
2020 Q2	$203K	Buy	+1,657	New	+$188K	0.21%	145
2020 Q1	–	Sell	-1,565	Closed	-$163K	–	553
2019 Q4	$163K	Buy	+1,565	New	+$175K	0.14%	168

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Samalin Investment Counsel's GWPH Position: Q1 2021 in Review

Samalin Investment Counsel sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,050 shares — an estimated $237K sold.

Samalin Investment Counsel first reported a position in GWPH in Q4 2019 and held it in 4 quarters. The position peaked at $237K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Samalin Investment Counsel reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Samalin Investment Counsel sold 2,050 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $237K.
Samalin Investment Counsel first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 4 quarters.
Samalin Investment Counsel's GW Pharmaceuticals Plc American Depositary Shares position peaked at $237K in Q4 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Samalin Investment Counsel's 13F filing for Q1 2021, filed 11 May 2021.